Psomagen, Inc. engages in the provision of multi-omics solutions for clinical and research purposes. The company provides genomics, a study of gene sequence and expression; epigenomics, a study of epigenetic changes, such as chromatin assembly, histone modification, and DNA-protein interaction in a cell; metagenomics, a study of genetic material from microorganisms in heterogeneous samples; transcriptomics, a study of RNA and its expression through sequencing, offered to analyze the impact of gene expression on the biology of an organism; and proteomics, a study of all the expressed proteins in an organism (proteome). It also offers Bioinformatics, a software tool and pipeline that helps scientists in analyzing data, as well as provides clinical testing solutions. The company was formerly known as Macrogen Corp. and changed its name to Psomagen, Inc. in April 2019. Psomagen, Inc. was incorporated in 2004 and is headquartered in Rockville, Maryland.